B
0.559
-0.02 (-3.90%)
| Penutupan Terdahulu | 0.582 |
| Buka | 0.577 |
| Jumlah Dagangan | 11,166 |
| Purata Dagangan (3B) | 856,281 |
| Modal Pasaran | 22,994,202 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2026 |
| EPS Cair (TTM) | -0.220 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 14.30% |
| Nisbah Semasa (MRQ) | 2.49 |
| Aliran Tunai Operasi (OCF TTM) | -15.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -12.95 M |
| Pulangan Atas Aset (ROA TTM) | -18.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | BeyondSpring, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -1.7 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | 0.15 |
|
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 15.26% |
| % Dimiliki oleh Institusi | 14.41% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |